Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas [Phase 1]
Itacitinib was studied in a Phase 1 trial for patients with refractory metastatic/advanced sarcomas, but the study status is TERMINATED.
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
This clinical trial update describes a biobank and patient registry for aggressive tumors to support translational and analytical research; …
-
FDA approval · 2024-04-23FDA Approved: PAZOPANIB — Original Application (Novugen Pharma (USA) LLC.)
FDA approved pazopanib hydrochloride as an original ANDA, enabling a generic version of pazopanib.
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma [Phase 3]
Phase 3 trial comparing L19TNF+Doxorubicin versus Doxorubicin alone as first-line therapy for advanced or metastatic soft tissue sarcoma is …
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas [Phase 1, Phase 2]
A Phase 1/2 trial evaluating nab-sirolimus in combination with pazopanib in advanced soft tissue sarcoma (including locally advanced and met…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery [NA]
Clinical trial update for adaptive staged stereotactic body radiation therapy in patients with spinal metastases, completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2024-02-29Clinical Trial Update: A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma [Phase 2]
Phase 2 trial update for SHR-1210 plus Apatinib in soft tissue sarcoma has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Preoperative vs Postoperative IMRT for Extremity/Truncal STS [Phase 3]
Phase 3 trial comparing preoperative versus postoperative IMRT for extremity/truncal soft tissue sarcoma is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma. [Phase 2]
Phase 2 clinical trial investigating albumin-bound paclitaxel plus camrelizumab for advanced soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. [Phase 2]
A Phase 2 trial evaluating palbociclib in second-line treatment of advanced sarcomas with CDK4 overexpression; current status unknown.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Phase II Study of TAEST16001 in Soft Tissue Sarcoma [Phase 2]
Phase II trial update is provided for TAEST16001 in soft tissue sarcoma, with the study status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04) [Phase 2]
Phase 2 trial ATLAS-IT-04 evaluating LTX-315 in combination with adoptive T-cell therapy for advanced soft tissue sarcoma has completed and …
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating doxorubicin with upfront dexrazoxane for advanced or metastatic soft tissue sarcoma has completed enrollment with r…
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg [Phase 2]
Phase 2 clinical trial evaluating isolated limb perfusion of melphalan with or without tumor necrosis factor for soft tissue sarcoma of the …
-
CLINICAL_TRIALS trial_result · 2023-10-27Clinical Trial Update: Use of GnRHa During Chemotherapy for Fertility Protection [Phase 3]
Phase 3 trial investigating GnRHa during chemotherapy to protect fertility in cancer patients; currently recruiting.
-
FDA approval · 2023-10-19FDA Approved: PAZOPANIB — Original Application (Apotex Corp.)
FDA approved an original Abbreviated New Drug Application for Pazopanib by Apotex Corp., providing a generic version of the cancer drug Pazo…
-
FDA approval · 2023-10-19FDA Approved: PAZOPANIB — Original Application (Teva Pharmaceuticals, Inc.)
FDA approval of a generic pazopanib product from Teva Pharmaceuticals under an Original Application (ANDA 217517).
-
FDA approval · 2023-10-19FDA Approved: PAZOPANIB — Original Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
FDA approved Sun Pharmaceutical's pazopanib as an original ANDA (generic) approval. The approval covers a generic version of pazopanib for t…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) [Phase 2]
Phase 2 trial update for treatment of metastatic soft tissue sarcoma (leiomyosarcoma) under FIBROSARC USA.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating YH001 plus Envafolimab with or without doxorubicin in advanced or metastatic sarcoma (including soft t…
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer [Phase 2]
Phase 2 trial of ADI-PEG 20 in combination with gemcitabine and docetaxel for soft tissue sarcoma, osteosarcoma, Ewing's sarcoma, and small …
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall [NA]
Phase II trial update on preoperative proton therapy for soft-tissue sarcomas of the extremities and body wall has completed with results po…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial evaluating perifosine for metastatic or locally advanced soft tissue sarcoma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial update on anlotinib as maintenance treatment for advanced soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: TVEC and Preop Radiation for Sarcoma (8 ml Dose) [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating talimogene laherparepvec (TVEC) with preoperative radiation for soft tissue sarcoma has posted results…